The Transcreener(R) ADP2 TR-fRET Red Assay is a competitive immunoassay for ADP with a far-red time-resolved foumlrster-resonance-energy-transfer (TR-fRET) readout. Because it is highly selective for ADP the assay can be used with any enzyme that converts ATP to ADP regardless of what other substrates are used. Examples of enzymes include protein lipid and carbohydrate kinases ATPases DNA helicases carboxylases and glutamine synthetase. The Transcreener(R) assay is designed specifically for high-throughput screening (HTS) with a single addition mix-and-read format. It offers reagent stability and compatibility with commonly used multimode plate readers. The generic nature of the Transcreener(R) HTS assay platform eliminates delays involved in assay development for new HTS targets and greatly simplifies compound and inhibitor profiling across multiple target families. The Transcreener(R) ADP2 TR-fRET Red Assay provides the following benefitsbullnbsp Accommodates ATP concentra